Inspire Medical approves board declassification and equity plan expansion with 38% opposition

Filed May 5, 2026 · Period ending April 30, 2026 · ~1 min read

Key Changes

• high

  Shareholders approved expanding the equity incentive plan by 2.6M shares to 9.9M total, but 38% voted against (8.8M against vs 14.3M for), signaling material concern about dilution despite the plan's passage.

  Item 5.03 — Amendments to Articles of Incorporation or Bylaws verify on EDGAR →
• medium

  Board declassification approved, phasing out staggered terms for annual director elections starting 2029. Amendment filed and effective May 1, 2026, increasing director accountability to shareholders.

  Item 5.03 — Amendments to Articles of Incorporation or Bylaws verify on EDGAR →
• medium

  Director Gary Ellis re-elected with 74.6% support (17.3M for, 5.9M withheld), notably lower than fellow Class II directors Melenikiotou (98.0%) and Mead (94.8%), suggesting some shareholder concern.

  Item 5.03 — Amendments to Articles of Incorporation or Bylaws verify on EDGAR →